Responses
E-Poster discussions
Poster Discussion with the Professor Station 1
IGCS19-0419
76 Patients (PTS) with recurrent gynecologic cancer whose tumors have activating wnt pathway mutations respond better to DKN-01, a DICKKOPF-1 (DKK1) inhibitor
Compose a Response to This Article
Other responses
No responses have been published for this article.